|
FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities |
|
Tuesday, October 22, 2024 07:27 AM |
|
The U.S. Food and Drug Administration has granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. The test, authorized for use without a prescription, is for use by individuals experiencing respiratory symptoms and uses a nasal swab sample to de liver at-home results in approximately 15 minutes for COVID-19 and influenza (flu). Read more.
|
